Evolution of breast cancer treatments: current options and quality-of-life considerations - European Journal of Oncology Nursing
Frontiers | Treatment of Breast Cancer With Gonadotropin-Releasing Hormone Analogs | Oncology
Utility of gonadotropin-releasing hormone agonists for fertility preservation in women receiving chemotherapy: pros and cons - Fertility and Sterility
Targeting of Steroid Hormone Receptor Function in Breast and Prostate Cancer | SpringerLink
Zoladex ca mammae
Advances in the Management of Metastatic Breast Cancer; Hormonal Therapy and Targeted Agents (Slides with Transcript)
New considerations for ADT in advanced prostate cancer and the emerging role of GnRH antagonists | Prostate Cancer and Prostatic Diseases
Considerations for the use of gonadotropin‐releasing hormone agonists and antagonists in patients with prostate cancer - Van Poppel - 2020 - International Journal of Urology - Wiley Online Library
Cardiovascular Effects of Androgen Deprivation Therapy in Prostate Cancer: Contemporary Meta-Analyses | Arteriosclerosis, Thrombosis, and Vascular Biology
Zoladex' (goserelin) - ppt video online download
Goserelin - wikidoc
Oncology
GnRH agonists and antagonists in prostate cancer - GaBI Journal
Ovarian protection with gonadotropin-releasing hormone agonists during chemotherapy in cancer patients: From biological evidence to clinical application - Cancer Treatment Reviews
Androgen–glucocorticoid interactions in the era of novel prostate cancer therapy | Nature Reviews Urology
Goserelin for Ovarian Protection during Breast-Cancer Adjuvant Chemotherapy | NEJM
Frontiers | Ovarian Function Suppression With Luteinizing Hormone-Releasing Hormone Agonists for the Treatment of Hormone Receptor-Positive Early Breast Cancer in Premenopausal Women | Oncology
Mechanism of action of luteinizing-hormone-releasing hormone analogues.... | Download Scientific Diagram
Androgen-targeted therapy in men with prostate cancer: evolving practice and future considerations | Prostate Cancer and Prostatic Diseases
Will GnRH antagonists improve prostate cancer treatment?: Trends in Endocrinology & Metabolism
Zoladex' (goserelin) adjuvant to radical
Abarelix for injectable suspension: first-in-class gonadotropin-releasing hormone antagonist for prostate cancer | Future Oncology
SciELO - Brasil - Use of anastrozole in the chemoprevention and treatment of breast cancer: A literature review Use of anastrozole in the chemoprevention and treatment of breast cancer: A literature review
Endocrinology of Prostate Cancer - ppt download
Hormone therapy for ovarian cancer: Emphasis on mechanisms and applications (Review)
Mode of action of antagonists of LHRH. (A) LHRH secreted by the... | Download Scientific Diagram
